However, despite the promising potential of SP-A and SP-D for modulating HIV infection and HIV mediated inflammation, the full impact of SP-A and SP-D on HIV infection and immunopathology in vivo and in the human disease is yet to be determined. The gene discussed is SFTPA2; the disease is HIV infectious disease.